Item 2.02 Results of Operations and Financial Condition.
On April 21, 2021, Anthem, Inc. issued a press release reporting its financial
results for the quarter ended March 31, 2021. A copy of the press release is
furnished as Exhibit 99.1 to this report and incorporated herein by reference.
None of the information furnished in Item 2.02 or Exhibit 99.1 hereto shall be
deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended. Unless expressly set forth by specific reference in such
filings, none of the information furnished in this report shall be incorporated
by reference in any filing under the Securities Act of 1933, as amended, whether
made before or after the date hereof and regardless of any general incorporation
language in such filings.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Exhibit
99.1 Press Release, dated April 21, 2021, reporting Anthem, Inc.
financial results for the quarter ended March 31, 2021.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
FORWARD-LOOKING STATEMENTS
This document contains certain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. Forward-looking statements
reflect our views about future events and financial performance and are
generally not historical facts. Words such as "expect," "feel," "believe,"
"will," "may," "should," "anticipate," "intend," "estimate," "project,"
"forecast," "plan" and similar expressions are intended to identify
forward-looking statements. These statements include, but are not limited to:
financial projections and estimates and their underlying assumptions; statements
regarding plans, objectives and expectations with respect to future operations,
products and services; and statements regarding future performance. Such
statements are subject to certain risks and uncertainties, many of which are
difficult to predict and generally beyond our control, that could cause actual
results to differ materially from those expressed in, or implied or projected
by, the forward-looking statements. You are cautioned not to place undue
reliance on these forward-looking statements that speak only as of the date
hereof. You are also urged to carefully review and consider the various risks
and other disclosures discussed in our reports filed with the U.S. Securities
and Exchange Commission from time to time, which attempt to advise interested
parties of the factors that affect our business. Except to the extent otherwise
required by federal securities laws, we do not undertake any obligation to
republish revised forward-looking statements to reflect events or circumstances
after the date hereof. These risks and uncertainties include, but are not
limited to: the impact of large scale medical emergencies, such as public health
epidemics and pandemics, including COVID-19, and catastrophes; trends in
healthcare costs and utilization rates; our ability to secure sufficient premium
rates, including regulatory approval for and implementation of such rates; the
impact of federal and state regulation, including ongoing changes in the Patient
Protection and Affordable Care Act and the Health Care and Education
Reconciliation Act of 2010, as amended (collectively, the "ACA") and the
ultimate outcome of legal challenges to the ACA; changes in economic and market
conditions, as well as regulations that may negatively affect our liquidity and
investment portfolios; our ability to contract with providers on cost-effective
and competitive terms; competitive pressures and our ability to adapt to changes
in the industry and develop and implement strategic growth opportunities;
reduced enrollment; unauthorized disclosure of member or employee sensitive or
confidential information, including the impact and outcome of any
investigations, inquiries, claims and litigation related thereto; risks and
uncertainties regarding Medicare and
--------------------------------------------------------------------------------
Medicaid programs, including those related to non-compliance with the complex
regulations imposed thereon; our ability to maintain and achieve improvement in
Centers for Medicare and Medicaid Services Star ratings and other quality scores
and funding risks with respect to revenue received from participation therein; a
negative change in our healthcare product mix; costs and other liabilities
associated with litigation (including the ultimate outcome of litigation between
Cigna Corporation and us related to the merger agreement between the parties),
government investigations, audits or reviews; risks and uncertainties related to
our pharmacy benefit management ("PBM"), business including non-compliance by
any party with the PBM services agreement between us and CaremarkPCS Health,
L.L.C.; medical malpractice or professional liability claims or other risks
related to healthcare and PBM services provided by our subsidiaries; general
risks associated with mergers, acquisitions, joint ventures and strategic
alliances; changes in U.S. tax laws; possible impairment of the value of our
intangible assets if future results do not adequately support goodwill and other
intangible assets; possible restrictions in the payment of dividends from our
subsidiaries and increases in required minimum levels of capital; our ability to
repurchase shares of our common stock and pay dividends on our common stock due
to the adequacy of our cash flow and earnings and other considerations; the
potential negative effect from our substantial amount of outstanding
indebtedness; a downgrade in our financial strength ratings; the effects of any
negative publicity related to the health benefits industry in general or us in
particular; failure to effectively maintain and modernize our information
systems; events that may negatively affect our licenses with the Blue Cross and
Blue Shield Association; the impact of international laws and regulations;
intense competition to attract and retain employees; and various laws and
provisions in our governing documents that may prevent or discourage takeovers
and business combinations.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses